Demographics, family histories, and psychological characteristics of prostate carcinoma screening participants

Cancer

Volumn 85, Issue 6, 1999, Pages 1305-1312

  Taylor, Kathryn L ^a   DiPlacido, Joanne ^b   Redd, William H ^b   Faccenda, Karen ^b   Greer, Linda ^c   Perlmutter, Aaron ^c  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Family history; Perceived risk; Prostate carcinoma screening; Psychological distress

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; DEMOGRAPHY; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PSYCHOLOGICAL ASPECT;

ATTITUDE TO HEALTH; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL;

EID: 0033559997     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990315)85:6<1305::AID-CNCR13>3.0.CO;2-I     Document Type: Article

References (37)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-29.
2. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, editors. SEER Cancer Statistics Review, 1973-1991: tables and graphs. NIH Publication No. 94-2789. Bethesda, MD: National Cancer Institute, 1994:369-79.
3. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995;273:548-52.
4. Cooner WH, Mosley BR, Rutherford CL, Beard JH, Pond HS, Terry WJ, et al. Prostate cancer detection in a clinical urological practice by ultrasonography digital rectal examination and prostate specific antigen. J Urol 1990;143:1146-54.
5. Lee F, Torp-Pedersen S, Littrup PJ, McLeary RD, McHugh TA, Smid AP, et al. Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen. Radiology 1989;170:29-32.
6. American Cancer Society. Can prostate cancer be found early? Available from the American Cancer Society website, URL:http://www.cancer.orig/cidSpecificCancers/prostate/ prearly.html.
7. Mainous AG, Hagen MD. Public awareness of prostate cancer and the prostate-specific antigen test. Cancer Pract 1994; 2:217-21.
8. Price JH, Colvin TL, Smith D. Prostate cancer: Perceptions of African-American males. J Natl Med Assoc 1993;85(12):941-47.
9. Chan ECY, Sulmasy DP. What should men know about prostate specific antigen screening before giving informed consent? J Gen Intern Med 1996;11:114.
10. Gohagan JK, Prorok PC, Kramer BS, Cornett JE. Prostate cancer screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial of the National Cancer Institute. J Urol 1994;152:1905-9.
11. Demark-Wahnefried W, Catoe KE, Paskett E, Robertson CN, Rimer BK. Characteristics of men reporting for prostate cancer screening. Urology 1993;42:269-75.
12. Flood A, Wennberg J, Nease R, Fowler F, Ding J, Hynes L. The importance of patient preference in the decision to screen for prostate cancer. J Gen Intern Med 1996;11:342-9.
13. Robinson SB, Ashley M, Haynes A. Attitudes of African Americans regarding screening for prostate cancer. J Natl Med Assoc 1996;88:241-6.
14. Thomas SM, Stotts RG, Dignan M. Increasing minority participation in prostate cancer screening. Presented at the Association for the Advancement of Behavior Therapy, 1993.
15. Myers R, Wolf T, Balshem A, Ross E, Chodak G. Receptivity of African-American men to prostate cancer screening. Urology 1994;43:480-7.
16. Myers R, Wolf R, McKee L, McGrory G, Burgh D, Nelson G, et al. Factors associated with intention to undergo annual prostate cancer screening among African American men in Philadelphia. Cancer 1996;78:471-9.
17. Demark-Wahnefried W, Strigo T, Catoe K, Conaway M, Brunetti M, Rimer BK, et al. Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening. Urology 1996;46:346-51.
18. Lerman C, Rimer B, Trock B, Balshem A, Engstrom PF. Factors associated with repeat adherence to breast cancer screening. Prev Med 1990;19:279-90.
19. Lipkus IM, Rimer BK, Strigo TS. Relationships among objective and subjective risk for breast cancer and mammography stages of change. Cancer Epidemiol Biomarkers Prev 1996;5: 1005-11.
20. McCaul KD, Schroeder DM, Reid PA. Breast cancer worry and screening: some prospective data. Health Psychol 1996; 15:430-3.
21. Polednak AP, Lane DS, Burg MA. Risk perception, family history, and use of breast cancer screening tests. Cancer Detect Prev 1991;15:257-63.
22. Bondy ML, Vogel VG, Halabi S, Lustbader ED. Identification of women at increased risk for breast cancer: a population-based screening program. Cancer Epidemiol Biomarkers Prev 1992;1:143-7.
23. Vernon SW, Vogel VG, Halabi S, Bondy ML. Factors associated with perceived risk of breast cancer among women attending a screening program. Breast Cancer Res Treat 1993;28:137-44.
24. Lerman C, Daly M, Sands C, Balshem A, Lustbader E, Heggan T, et al. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 1993;85:1074-80.
25. Lerman C, Schwartz MD. Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat 1993;28:145-55.
26. Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992;84:24-30.
27. McCaul KD, Branstetter AD, Schroeder DM, Glasgow RE. What is the relationship between breast cancer risk and mammography screening? a meta-analytic review. Health Psychol 1996;15:423-9.
28. Schwartz MD, Lerman C, Daly M, Audrain J, Masny A, Griffith K. Utilization of ovarian cancer screening by women at increased risk. Cancer Epidemiol Biomarkers Prev 1995(a);4: 269-73.
29. Lerman C, Schwartz MD, Lin TH, Narond S, Lynch HT. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 1997;65:414-20.
30. Valdimarsdottir HB, Bovbjerg DH, Kash KM, Holland JC, Osborne MP, Miller DG. Psychological distress in women with a familial risk of breast cancer. Psychooncology 1995;4: 133-41.
31. Horowitz M, Wilner N, Alvarez W. Impact of events scale: a measure of subjective stress. Psychosom Med 1979;41:209-18.
32. Shacham S. A shortened version of the Profile of Mood States. J Pers Assess 1983;47:305-6.
33. Guadagnoli E, Mor V. Measuring cancer patients' affect: revision and psychometric properties of the Profile of Mood States (POMS). Psychol Assess J Consult Clin Psychol 1989;1: 150-4.
34. Manne SL, Sabbioni M, Bovbjerg DH, Jacobsen PB, Taylor KL, Redd WH. Coping with chemotherapy for breast cancer. J Behav Med 1994;17:41-55.
35. Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A. Psychological side effects of breast cancer screening. Health Psychol 1991;10:259-67.
36. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991;114:657-61.
37. Daly MB, Lerman CL, Ross E, Schwartz MD, Sands CB, Masny A. Gail model breast cancer risk components are poor predictors of risk perception and screening behavior. Breast Cancer Res Treat 1996;41:59-70.